Scarlet Therapeutics raises seed funding to develop red blood cell platform

Scarlet Therapeutics, a leader in red blood cell-based therapeutics, has raised seed funding from Science Creates Ventures and Meltwind to develop its platform and build a pipeline of novel therapies.

Related Keywords

Bristol ,City Of ,United Kingdom ,Cambridge ,Cambridgeshire ,Jan Frayne ,Alistair Irvine ,University Of Bristol ,Professor Ash Toye ,Professor Jan Frayne ,Markets Amp Regulations ,Antibody Drug Conjugates ,Emerging Markets ,Red Blood Cell ,Herapeutics ,Flood ,